Literature DB >> 29769959

Vaccines for adults: The time has come.

I Gemmill1,2.   

Abstract

The benefits of vaccines for adults have been underappreciated because of the focus on childhood vaccines. However, precisely because of the success of immunization programs for children, most deaths from vaccine-preventable diseases now occur amongst adults. Tetanus boosters will help to maintain Canada's low tetanus rates and pertussis boosters for adults are now available. Human papilloma virus vaccine may be indicated in some older adults. Hepatitis A and B vaccines may be indicated if there is occupational, travel or lifestyle risk. Pneumococcal and zoster vaccines are recommended in those over 65 years of age, and all adults benefit from annual influenza vaccination. A systematic approach to immunizing adults would assist in ensuring that all who are eligible for specific vaccines are offered them. This approach would include promoting routine immunization as a fundamental part of every patient encounter and the use of tools, such as the Adult Immunization Questionnaire and the Adult Immunization Wallet Card. By investing in these strategies, the health of adults can be improved significantly.

Entities:  

Year:  2015        PMID: 29769959      PMCID: PMC5868635          DOI: 10.14745/ccdr.v41is3a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  10 in total

1.  Infant pertussis: what to do next?

Authors:  C Mary Healy; Carol J Baker
Journal:  Clin Infect Dis       Date:  2011-12-08       Impact factor: 9.079

2.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  Barriers to adult immunization.

Authors:  David R Johnson; Kristin L Nichol; Kim Lipczynski
Journal:  Am J Med       Date:  2008-07       Impact factor: 4.965

4.  Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) .

Authors:  Dr M Dawar; Ms T Harris; Dr S McNeil
Journal:  Can Commun Dis Rep       Date:  2012-01-02

5.  An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.

Authors:  Punam Mangtani; Jennifer A Roberts; Andrew J Hall; Felicity T Cutts
Journal:  Int J Epidemiol       Date:  2005-03-11       Impact factor: 7.196

6.  Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population.

Authors:  Carlos Castañeda-Orjuela; Nelson Alvis-Guzmán; Angel José Paternina; Fernando De la Hoz-Restrepo
Journal:  Vaccine       Date:  2011-08-18       Impact factor: 3.641

7.  Physician practices and attitudes regarding adult immunizations.

Authors:  Peter G Szilagyi; Laura P Shone; Richard Barth; Ruth W Kouides; Christine Long; Sharon G Humiston; Jackie Jennings; Nancy M Bennett
Journal:  Prev Med       Date:  2005-02       Impact factor: 4.018

8.  Cost effectiveness of herpes zoster vaccine in Canada.

Authors:  Mehdi Najafzadeh; Carlo A Marra; Eleni Galanis; David M Patrick
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  A cost-benefit analysis of immunization for pneumococcal pneumonia.

Authors:  K M Patrick; F R Woolley
Journal:  JAMA       Date:  1981-02-06       Impact factor: 56.272

10.  Improving preventive service delivery at adult complete health check-ups: the Preventive health Evidence-based Recommendation Form (PERFORM) cluster randomized controlled trial.

Authors:  Vinita Dubey; Roy Mathew; Karl Iglar; Rahim Moineddin; Richard Glazier
Journal:  BMC Fam Pract       Date:  2006-07-12       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.